eHealth (EHTH) Competitors $4.81 -0.15 (-3.02%) Closing price 04:00 PM EasternExtended Trading$4.94 +0.14 (+2.81%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EHTH vs. MMC, AJG, AON, BRO, CRD.B, HUIZ, OXBR, WTW, RYAN, and ERIEShould you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), Arthur J. Gallagher & Co. (AJG), AON (AON), Brown & Brown (BRO), Crawford & Company (CRD.B), Huize (HUIZ), Oxbridge Re (OXBR), Willis Towers Watson Public (WTW), Ryan Specialty (RYAN), and Erie Indemnity (ERIE). eHealth vs. Its Competitors Marsh & McLennan Companies Arthur J. Gallagher & Co. AON Brown & Brown Crawford & Company Huize Oxbridge Re Willis Towers Watson Public Ryan Specialty Erie Indemnity eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MMC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment. Is EHTH or MMC more profitable? Marsh & McLennan Companies has a net margin of 16.00% compared to eHealth's net margin of 6.10%. Marsh & McLennan Companies' return on equity of 31.90% beat eHealth's return on equity.Company Net Margins Return on Equity Return on Assets eHealth6.10% 2.85% 1.45% Marsh & McLennan Companies 16.00%31.90%8.29% Do institutionals and insiders have more ownership in EHTH or MMC? 79.5% of eHealth shares are owned by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are owned by institutional investors. 5.2% of eHealth shares are owned by insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer EHTH or MMC? In the previous week, Marsh & McLennan Companies had 23 more articles in the media than eHealth. MarketBeat recorded 31 mentions for Marsh & McLennan Companies and 8 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.12 beat eHealth's score of 0.57 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment eHealth 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marsh & McLennan Companies 22 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, EHTH or MMC? eHealth has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Marsh & McLennan Companies has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Do analysts recommend EHTH or MMC? eHealth presently has a consensus price target of $7.67, indicating a potential upside of 59.39%. Marsh & McLennan Companies has a consensus price target of $237.47, indicating a potential upside of 15.99%. Given eHealth's higher possible upside, equities analysts plainly believe eHealth is more favorable than Marsh & McLennan Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eHealth 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Marsh & McLennan Companies 2 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.21 Which has higher earnings and valuation, EHTH or MMC? Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeHealth$532.41M0.28$10.06M-$0.63-7.63Marsh & McLennan Companies$24.46B4.12$4.06B$8.3424.55 SummaryMarsh & McLennan Companies beats eHealth on 13 of the 16 factors compared between the two stocks. Get eHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHTH vs. The Competition Export to ExcelMetriceHealthINS IndustryFinance SectorNASDAQ ExchangeMarket Cap$146.99M$26.38B$12.65B$10.65BDividend YieldN/A1.20%5.52%4.74%P/E Ratio-7.6355.2530.1727.59Price / Sales0.284.8230.25138.47Price / Cash243.1737.8422.6661.77Price / Book0.244.782.296.76Net Income$10.06M$835.86M$1.02B$275.88M7 Day Performance15.35%3.85%0.34%3.72%1 Month Performance23.02%3.15%0.41%10.22%1 Year Performance12.91%-4.36%539.27%35.86% eHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHTHeHealth4.0916 of 5 stars$4.81-3.0%$7.67+59.4%+12.2%$151.56M$532.41M-7.631,773News CoveragePositive NewsAnalyst ForecastMMCMarsh & McLennan Companies4.9264 of 5 stars$199.99+0.2%$238.76+19.4%-7.3%$98.11B$25.80B23.9890,000Positive NewsAnalyst ForecastAJGArthur J. Gallagher & Co.4.8336 of 5 stars$305.40+0.4%$330.93+8.4%+7.9%$77.98B$11.40B43.3856,000Positive NewsAnalyst ForecastAONAON4.4441 of 5 stars$354.28-0.5%$414.69+17.1%+6.8%$76.78B$15.70B29.6760,000Trending NewsAnalyst ForecastBROBrown & Brown4.7208 of 5 stars$92.91-0.9%$112.08+20.6%-6.5%$30.93B$4.81B26.7717,403Trending NewsAnalyst ForecastCRD.BCrawford & CompanyN/A$9.94-3.6%N/A-13.4%$511.79M$1.34B16.8410,040Positive NewsHUIZHuize0.9517 of 5 stars$3.46+1.5%$2.30-33.5%-83.6%$34.40M$171.10M115.331,640Analyst ForecastOXBROxbridge Re1.5727 of 5 stars$1.95-0.8%$5.00+157.1%-28.0%$14.97M$550K-4.743Analyst ForecastWTWWillis Towers Watson Public2.9933 of 5 stars$342.20+0.1%$363.42+6.2%+21.5%$33.35B$9.81B234.3948,900Trending NewsAnalyst ForecastAnalyst RevisionRYANRyan Specialty4.5942 of 5 stars$55.83+0.4%$73.92+32.4%-16.6%$14.66B$2.52B159.515,250Analyst ForecastERIEErie Indemnity2.6211 of 5 stars$313.25-0.9%N/A-38.8%$14.60B$3.80B26.196,801Positive NewsAnalyst Forecast Related Companies and Tools Related Companies MMC Alternatives AJG Alternatives AON Alternatives BRO Alternatives CRD.B Alternatives HUIZ Alternatives OXBR Alternatives WTW Alternatives RYAN Alternatives ERIE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EHTH) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
